208 related articles for article (PubMed ID: 15832445)
1. Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.
Atkins WM
Annu Rev Pharmacol Toxicol; 2005; 45():291-310. PubMed ID: 15832445
[TBL] [Abstract][Full Text] [Related]
2. "Allosterism" in the elementary steps of the cytochrome P450 reaction cycle.
Yoon MY; Campbell AP; Atkins WM
Drug Metab Rev; 2004 May; 36(2):219-30. PubMed ID: 15237852
[TBL] [Abstract][Full Text] [Related]
3. Atypical Michaelis-Menten kinetics in cytochrome P450 enzymes: A focus on substrate inhibition.
Leow JWH; Chan ECY
Biochem Pharmacol; 2019 Nov; 169():113615. PubMed ID: 31445022
[TBL] [Abstract][Full Text] [Related]
4. Is there a toxicological advantage for non-hyperbolic kinetics in cytochrome P450 catalysis? Functional allostery from "distributive catalysis".
Atkins WM; Lu WD; Cook DL
J Biol Chem; 2002 Sep; 277(36):33258-66. PubMed ID: 12082118
[TBL] [Abstract][Full Text] [Related]
5. Substrate inhibition kinetics for cytochrome P450-catalyzed reactions.
Lin Y; Lu P; Tang C; Mei Q; Sandig G; Rodrigues AD; Rushmore TH; Shou M
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):368-74. PubMed ID: 11259318
[TBL] [Abstract][Full Text] [Related]
6. Challenges in assignment of allosteric effects in cytochrome P450-catalyzed substrate oxidations to structural dynamics in the hemoprotein architecture.
Hlavica P
J Inorg Biochem; 2017 Feb; 167():100-115. PubMed ID: 27919007
[TBL] [Abstract][Full Text] [Related]
7. Allosteric phenomena in cytochrome P450-catalyzed monooxygenations.
Hlavica P; Lewis DF
Eur J Biochem; 2001 Sep; 268(18):4817-32. PubMed ID: 11559350
[TBL] [Abstract][Full Text] [Related]
8. Atypical cytochrome p450 kinetics: implications for drug discovery.
Tracy TS
Drugs R D; 2006; 7(6):349-63. PubMed ID: 17073518
[TBL] [Abstract][Full Text] [Related]
9. Enzyme kinetics of cytochrome P450-mediated reactions.
Shou M; Lin Y; Lu P; Tang C; Mei Q; Cui D; Tang W; Ngui JS; Lin CC; Singh R; Wong BK; Yergey JA; Lin JH; Pearson PG; Baillie TA; Rodrigues AD; Rushmore TH
Curr Drug Metab; 2001 Mar; 2(1):17-36. PubMed ID: 11465149
[TBL] [Abstract][Full Text] [Related]
10. Enzyme kinetics of oxidative metabolism: cytochromes P450.
Korzekwa K
Methods Mol Biol; 2014; 1113():149-66. PubMed ID: 24523112
[TBL] [Abstract][Full Text] [Related]
11. Fundamentals of Enzyme Kinetics: Michaelis-Menten and Non-Michaelis-Type (Atypical) Enzyme Kinetics.
Seibert E; Tracy TS
Methods Mol Biol; 2021; 2342():3-27. PubMed ID: 34272689
[TBL] [Abstract][Full Text] [Related]
12. Autoactivation and activation of the cytochrome P450s.
Ekins S; Ring BJ; Binkley SN; Hall SD; Wrighton SA
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):642-51. PubMed ID: 9877001
[TBL] [Abstract][Full Text] [Related]
13. In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model.
Houston JB; Kenworthy KE
Drug Metab Dispos; 2000 Mar; 28(3):246-54. PubMed ID: 10681367
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.
Yadav J; Paragas E; Korzekwa K; Nagar S
Pharmacol Ther; 2020 Feb; 206():107449. PubMed ID: 31836452
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4.
Isin EM; Guengerich FP
J Biol Chem; 2006 Apr; 281(14):9127-36. PubMed ID: 16467307
[TBL] [Abstract][Full Text] [Related]
16. Current views on the fundamental mechanisms of cytochrome P450 allosterism.
Atkins WM
Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):573-9. PubMed ID: 16859405
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of P450 inhibition and activation: implications for drug development and drug therapy.
Szklarz GD; Halpert JR
Drug Metab Dispos; 1998 Dec; 26(12):1179-84. PubMed ID: 9860924
[TBL] [Abstract][Full Text] [Related]
18. Enzyme Kinetics of Oxidative Metabolism-Cytochromes P450.
Korzekwa K
Methods Mol Biol; 2021; 2342():237-256. PubMed ID: 34272697
[TBL] [Abstract][Full Text] [Related]
19. Use of density functional theory in drug metabolism studies.
Rydberg P; Jørgensen FS; Olsen L
Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):215-27. PubMed ID: 24295134
[TBL] [Abstract][Full Text] [Related]
20. [Research progress of the atypical kinetic profiles of cytochrome P450 enzymes].
Zeng CW; He F; Xia CH; Xiong YQ
Yao Xue Xue Bao; 2012 Jun; 47(6):725-9. PubMed ID: 22919718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
